SCHEMBL15775797

SCHEMBL15775797

NC(=O)c1cc(OCC(F)(F)F)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPT P10636 3/20 0.42
OPRK1 P41145 1/20 0.42
KCNH2 Q12809 1/20 0.42
KMT2A Q03164 3/20 0.41
GSK3B P49841 1/20 0.41
SCN9A Q15858 1/20 0.41
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
S1PR2 O95136 1/20 0.40
S1PR4 O95977 1/20 0.40
GAA P10253 1/20 0.40
XBP1 P17861 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2714102 0.86 ALDH1A1 (0.47) CYP1A2CYP2C9KDM4EALDH1A1MAPT
SCHEMBL2715909 0.84 ALDH1A1 (0.46) RAF1CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL27913654 0.82 ALDH1A1 (0.44) RAF1CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL13028341 0.82 MAPT (0.40) RAF1CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL2335940 0.82 MAPT (0.40) RAF1CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL28130114 0.81 ALDH1A1 (0.59) RAF1CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL15777791 0.79 HTR1A (0.47) RAF1ALDH1A1MAPTOPRK1KCNH2
SCHEMBL17396881 0.79 CYP1A2 (0.42) CYP1A2CYP2C9KDM4EALDH1A1MAPT
SCHEMBL11617771 0.79 PARP10 (0.51) RAF1CYP1A2KDM4EALDH1A1MAPT
SCHEMBL30438262 0.79 PARP10 (0.51) RAF1CYP1A2KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928867-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. Hoffmann-La Roche AG (CH) 2015-10-14 EP claimed
WO-2014086805-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2014-06-12 WO claimed
CN-104837818-B It can be used as the acid amides of pyridine 2 of CB2 activators 霍夫曼-拉罗奇有限公司 2017-07-14 CN disclosed
EP-2928867-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. Hoffmann-La Roche AG (CH) 2015-10-14 EP disclosed
WO-2014086805-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2014-06-12 WO disclosed